If you wake up congested, sneeze through the morning, or notice your skin and breathing get worse indoors, the dust in your home may be doing more than you think. The proteins in house dust, particularly from microscopic dust mites that live in bedding, carpets, and upholstered furniture, are among the most common indoor triggers of allergic disease worldwide.
This test measures whether your immune system has produced antibodies against those dust proteins. A positive result points to a specific, treatable trigger behind allergic rhinitis, asthma, atopic dermatitis, and allergic eye disease, and it changes what you can actually do about your symptoms.
The analyte is IgE (immunoglobulin E), a class of antibody made by your immune system's B cells after they encounter and react to an outside protein. The Greer house dust extract used on the test surface contains a complex mix of proteins from house dust, with house dust mite proteins being the dominant allergens. When your blood is exposed to that extract, the assay measures how much IgE in your sample binds to it.
A positive result means your immune system has been trained to recognize something in house dust as a threat. That sensitization is the biological starting point for the allergic reactions you feel as runny nose, itchy eyes, wheezing, or eczema flares. Importantly, sensitization on a blood test is not the same as guaranteed clinical allergy, a distinction we will come back to.
House dust mite IgE is one of the strongest indoor triggers of perennial allergic rhinitis, the year-round version of hay fever. In a Japanese study of 17,974 elementary school children, 18.8% had allergic rhinitis caused by house dust mites, a meaningful share of childhood symptoms that often gets dismissed as a permanent cold.
In children with allergic conjunctivitis, higher house dust mite IgE levels were linked to a higher likelihood of having other allergic diseases at the same time, including rhinitis, asthma, and eczema. A study of 2,972 children found that the higher the dust mite IgE, the more comorbid allergic conditions were present, meaning a high level is a signal that the immune response has spread across multiple tissues.
Children with house dust mite allergy and asthma show a wider range of IgE responses to mite proteins and higher overall levels than allergic children without asthma. In a study of 211 children, the asthmatic group recognized more individual mite proteins and had higher concentrations of IgE against them, suggesting that the breadth and intensity of sensitization track with respiratory disease severity.
Long-term exposure data backs this up. In a prospective study of 67 children followed from infancy, those exposed to higher levels of house dust mite allergen in early life were more likely to develop asthma later in childhood, with wheeze starting earlier in life. Higher mite IgE is not a passive observation, it tracks a process that shapes lung health over years.
In people with eczema, IgE to certain dust mite proteins is linked to more severe skin disease. A study of 384 atopic patients found that sensitization to specific mite components (Der p 5, 20, and 21) was associated with both allergic asthma and atopic dermatitis, and incorporating these into testing improved how well clinicians could assess severity.
In infants under two years old, early house dust mite sensitization was associated with higher rates of atopic dermatitis and food allergies in a study of 1,793 children. For parents trying to understand why a baby's skin keeps flaring, a positive dust IgE can identify a specific trigger that environmental measures and treatment can target.
A positive house dust IgE means you are sensitized. It does not automatically mean your symptoms are caused by dust. Among people who tested positive on both blood IgE and skin prick testing, only about 69 to 70% had their dust mite allergy confirmed by a nasal provocation test, the most direct check for whether exposure actually reproduces symptoms.
This is why a positive result is best read alongside your symptom pattern. If your nose runs when you change the sheets, if you wake up congested, if your asthma worsens in dusty rooms, a positive test moves dust mites from suspicion to high-confidence trigger. If you have no symptoms, a positive test still tells you something important: your immune system is primed, and clinical allergy can develop later, especially in children.
These cutoffs come from a study of 16,209 adults and children with allergic rhinitis in Korea using the ImmunoCAP assay, validated against skin prick test results. They are illustrative orientation, not a target. Your lab will likely report different numbers, and the optimal threshold for calling a result positive varies by age and by which mite species is measured.
| Tier | Range (kU/L) | What It Suggests |
|---|---|---|
| Negative | Below 0.35 | No detectable IgE sensitization to house dust |
| Low positive | 0.35 to 0.70 | Sensitization present, clinical relevance often uncertain |
| Clinically suggestive | Above 0.69 to 1.16 | Levels above this threshold more reliably correspond to a positive skin prick test and clinical dust mite allergy |
Compare your results within the same lab over time for the most meaningful trend. The 0.35 kU/L cutoff is the traditional positivity threshold, but research shows it can both miss clinically relevant sensitization and label some sensitized people as having significant allergy when they may not.
A single dust IgE reading tells you whether you are sensitized today. The more useful information comes from how that number moves over months and years, especially if you are doing something about it. Allergen immunotherapy (the standard medical treatment for dust mite allergy) shifts antibody levels in characteristic ways: dust mite IgE often rises in the first months of treatment before slowly falling, and the pattern of change predicts who will respond best.
For most people, a sensible cadence is to get a baseline, retest 6 to 12 months after starting any allergen-targeted treatment or major environmental change, and then check annually if you are actively managing dust mite allergy. If you are stable and asymptomatic, less frequent testing is reasonable, but a once-and-done result misses the trajectory that actually matters.
A few situations can distort how a single reading should be interpreted:
If your dust IgE is positive and your symptoms fit, the immediate next steps fall into three categories. First, confirm the clinical picture with an allergist if you are considering immunotherapy, since blood testing alone is not enough to commit to a multi-year treatment. Skin prick testing or nasal provocation can sharpen the diagnosis. Second, reduce exposure where it counts most, which is your bedroom. Mite-impermeable mattress and pillow encasings have the strongest evidence for reducing emergency hospital attendance for childhood asthma exacerbations.
Third, consider whether the broader allergic picture warrants further workup. A high dust IgE often comes with sensitization to other indoor allergens (pets, mold, cockroach), and a fuller environmental panel may be worth ordering. If you have asthma symptoms alongside dust sensitization, lung function testing and an asthma management plan with an allergist or pulmonologist is the next step. The goal is not just to know you are allergic, but to act on it.
Evidence-backed interventions that affect your House Dust (Greer) IgE level
House Dust (Greer) IgE is best interpreted alongside these tests.